Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF C188-9, VENETOCLAX, AND BUMETANIDE IN DRUG FOR FIBROTIC DISEASES
Document Type and Number:
WIPO Patent Application WO/2022/027953
Kind Code:
A1
Abstract:
Disclosed is the use of C188-9, Venetoclax, and Bumetanide in a drug for fibrotic diseases. From a clinical view, an RNA recognition motif (RRM) region of the LARP6 protein is used as a docking target, and is subjected to computer virtual docking and simulated screening. Finally it is found by means of cellular and animal experiments that, in the process of the occurrence and development of injury-induced fibrosis, by means of combining C188-9, Venetoclax and Bumetanide (a potent quick-acting diuretic commonly used clinically) with the RRM region of the LARP6 protein so as to inhibit the stability of collagen mRNA, collagen production is inhibited, and as such fibrosis-related diseases are inhibited. The content of basic research of the pathogenesis of fibrosis-related diseases is enriched, and a new way of thinking is provided for the deeper exploration of the essential causes of fibrotic disease pathogenesis. Moreover, C188-9, Venetoclax, and Bumetanide can be considered as a new potential drug for the clinical treatment of fibrotic diseases.

Inventors:
YU YING (CN)
ZUO SHENGKAI (CN)
SHEN YUJUN (CN)
CUI HUI (CN)
Application Number:
PCT/CN2021/076760
Publication Date:
February 10, 2022
Filing Date:
February 18, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV TIANJIN MEDICAL (CN)
International Classes:
A61K31/18; A61K31/635; A61P1/16; A61P1/18; A61P7/00; A61P9/00; A61P11/00; A61P13/12; A61P15/00; A61P19/08; A61P27/02; A61P37/02; C07C311/29; C07C311/39; C07D471/04
Domestic Patent References:
WO2015010102A12015-01-22
WO2010062640A12010-06-03
WO2015010107A12015-01-22
Foreign References:
CN111973578A2020-11-24
CN106163557A2016-11-23
CN105377289A2016-03-02
Other References:
LI ZILONG, CHEN BAOYU, DONG WENHUI, KONG MING, FAN ZHIWEN, YU LIMING, WU DONGMEI, LU JUN, XU YONG: "MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription", CELL DEATH & DISEASE, NATURE PUBLISHING GROUP, GB, vol. 10, no. 12, 1 December 2019 (2019-12-01), GB , pages 899 - 13, XP055895102, ISSN: 2041-4889, DOI: 10.1038/s41419-019-2101-4
TENG KUN-YU, BARAJAS JUAN M., HU PENG, JACOB SAMSON T., GHOSHAL KALPANA: "Role of B Cell Lymphoma 2 in the Regulation of Liver Fibrosis in miR-122 Knockout Mice", BIOLOGY, MDPI, CH, vol. 9, no. 7, 1 July 2020 (2020-07-01), CH , pages 157 - 18, XP055895113, ISSN: 2079-7737, DOI: 10.3390/biology9070157
VAN ANDEL DORINDE M., SPRENGERS JAN J., ORANJE BOB, SCHEEPERS FLOORTJE E., JANSEN FLOOR E., BRUINING HILGO: "Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study", MOLECULAR AUTISM, BIOMED CENTRAL LTD, LONDON, UK, vol. 11, no. 1, 1 December 2020 (2020-12-01), London, UK , pages 30 - 14, XP055895117, ISSN: 2040-2392, DOI: 10.1186/s13229-020-00335-4
SHUANG LIU, YISHENG LIU, SIQI YING, LINRONG PAN, GENGRU JIANG: "Function of NKCC1 in the Aortic Fibrosis of Rats with Chronic Kidney Disease", CHINESE JOURNAL OF CELL BIOLOGY, ZHONGGUO KEXUEYUAN SHANGHAI SHENGMING KEXUE YANJIUYUAN SHENGWU HUAXUE YU XIBAO SHENGWUXUE YANJIUSUO, CN, vol. 42, no. 5, 1 January 2020 (2020-01-01), CN , pages 763 - 771, XP055895141, ISSN: 1674-7666, DOI: 10.11844/cjcb.2020.05.0003
PEDROZA MESIAS, TO SARAH, ASSASSI SHERVIN, WU MINGHUA, TWEARDY DAVID, AGARWAL SANDEEP K: "Role of STAT3 in skin fibrosis and transforming growth factor beta signalling", RHEUMATOLOGY, OXFORD UNIVERSITY PRESS, LONDON, GB, vol. 57, no. 10, 1 October 2018 (2018-10-01), GB , pages 1838 - 1850, XP055895142, ISSN: 1462-0324, DOI: 10.1093/rheumatology/kex347
SAMANANI SHAZIA; MISHRA MANOJ; SILVA CLAUDIA; VERHAEGHE BROOKE; WANG JANET; TONG JADE; YONG V WEE: "Screening for Inhibitors of Microglia to Reduce Neuroinflammation", CNS & NEUROLOGICAL DISORDERS, BENTHAM SCIENCE PUBLISHERS LTD.,, NL, vol. 12, no. 6, 1 September 2013 (2013-09-01), NL , pages 741 - 749, XP009194559, ISSN: 1871-5273, DOI: 10.2174/18715273113126660177
Attorney, Agent or Firm:
TIANJIN BINHAI KEWEI INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: